Favourable safety and tolerability profile of coadministered amlodipine and atorvastatin in patients with concomitant hypertension and dyslipidemia: Results from the respond trial

被引：0
|
作者：
Preston, R. A.
Jukema, J. W.
Harvey, P.
Sun, F.
Tarasenko, L.
机构：
[1] Univ Miami, Miller Sch Med, Div Clin Pharmacol & Pharmacokinet, Miami, FL 33152 USA
[2] Leiden Univ, Med Ctr, Dept Cardiol C5 P, Leiden, Netherlands
[3] Crouch Oak Family Practice, Addlestone, Surrey, England
[4] Pfizer Inc, New York, NY USA
来源：
JOURNAL OF HYPERTENSION | 2006年 / 24卷
关键词：
D O I：
暂无
中图分类号：
R6 [外科学];
学科分类号：
1002 ; 100210 ;
摘要：
引用
收藏
页码：S82 / S83
页数：2
相关论文
共 50 条
  • [31] A randomized, double-blind, multicenter, phase III study on the efficacy and safety of a combination treatment involving fimasartan, amlodipine, rosuvastatin in patients with essential hypertension and dyslipidemia who fail to respond adequately to fimasartan monotherapy
    Eun-Seok Jeon
    Sang Wook Lim
    Seok-Yeon Kim
    Hyoung-Mo Yang
    Moo Hyun Kim
    Moo-Yong Rhee
    Seung Hwan Han
    Jinho Shin
    Kwang-il Kim
    Jin-Ok Jeong
    Ki Chul Sung
    Geu Ru Hong
    Hyung-Seop Kim
    Kihwan Kwon
    Tae-Soo Kang
    Hae-Young Lee
    Su-Eun Han
    Clinical Hypertension, 28
  • [32] CLINICAL PROFILE OF ACUTE MYOCARDIAL INFARCTION PATIENTS WITH AND WITHOUT HYPERTENSION: RESULTS FROM THE YOGA-CARE TRIAL
    Soni, Divya
    Singh, Kalpana
    Ambalam, Chandrasekaran
    Vamadevan, Ajay
    Kinra, Sanjay
    Singh, Kavita
    Praveen, P. A.
    Devarajan, Raji
    Mohan, Bishav
    Chadha, Davinder Singh
    Negi, Prakash Chand
    Prabhavati
    Kumar, Sunil
    Sadananda, K. S.
    Manchanda, Subhash Chand
    Sarma, P. V. Raghava
    Chandra, Sharad
    Prasad, M. R.
    Dorairaj, Prabhakaran
    JOURNAL OF HYPERTENSION, 2018, 36 : E229 - E230
  • [33] Long-term safety and tolerability of lacosamide monotherapy in patients with epilepsy: Results from a multicenter, open-label trial
    Ben-Menachem, Elinor
    Dominguez, Jacqueline
    Szasz, Jozsef
    Beller, Cynthia
    Howerton, Charles
    Jensen, Lori
    McClung, Carrie
    Roebling, Robert
    Steiniger-Brach, Bjorn
    EPILEPSIA OPEN, 2021, 6 (03) : 618 - 623
  • [34] Safety and tolerability of suvodirsen (WVE-210201) in patients with Duchenne muscular dystrophy: results from a phase 1 clinical trial
    Wagner, K.
    Phan, H.
    Servais, L.
    Gidaro, T.
    Cripe, L.
    Eagle, M.
    Muntoni, F.
    Straub, V.
    Lonkar, P.
    Schmitz, S.
    Lake, S.
    Hu, X.
    Panzara, M.
    NEUROMUSCULAR DISORDERS, 2019, 29 : S124 - S124
  • [35] Real-life Effectiveness and Safety of Amlodipine/Valsartan Single-pill Combination in Patients with Hypertension in Egypt: Results from the EXCITE Study
    Assaad-Khalil S.H.
    Nashaat N.
    Drugs - Real World Outcomes, 2016, 3 (3) : 307 - 315
  • [36] Efficacy, Safety, and Tolerability of Inclisiran in Patients With Homozygous Familial Hypercholesterolemia: Results From the ORION-5 Randomized Clinical Trial
    Raal, Frederick
    Durst, Ronen
    Bi, Ran
    Talloczy, Zsolt
    Maheux, Pierre
    Lesogor, Anastasia
    Kastelein, John J. P.
    CIRCULATION, 2024, 149 (05) : 354 - 362
  • [37] Safety and tolerability of efalizumab therapy: 60 weeks results from a phase IIIb trial in moderate-to-severe plaque patients with psoriasis
    Menter, A
    BRITISH JOURNAL OF DERMATOLOGY, 2006, 154 (01)
  • [38] Safety and Tolerability of AZD0466 As Monotherapy for Patients with Advanced Hematologic Malignancies. Results from a Phase I/II Trial
    Arslan, Shukaib
    Marconi, Giovanni
    Martinelli, Giovanni
    Fleming, Shaun
    Curti, Antonio
    Dinner, Shira N.
    Blachly, James S.
    Della Porta, Matteo Giovanni
    Bajel, Ashish
    Sauer, Tim
    Crysandt, Martina
    Pigneux, Arnaud
    Fransecky, Lars
    Baldus, Claudia D.
    Konopleva, Marina Y.
    Marmor, Yotvat
    Sharma, Shringi
    Elgeioushi, Nairouz
    Cheung, Patricia
    Rowe, Emily
    Jahn, Ekaterina
    Yu, Ting
    Saeh, Jamal
    Tibes, Raoul
    Cader, Fathima Zumla
    Jain, Nitin
    BLOOD, 2023, 142
  • [39] Ixekizumab sustains high level of efficacy and favourable safety profile over 4 years in patients with moderate psoriasis: results from UNCOVER-3 study
    Lebwohl, M. G.
    Gordon, K. B.
    Gallo, G.
    Zhang, L.
    Paul, C.
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2020, 34 (02) : 301 - 309
  • [40] Long-term safety profile of bosentan in patients with systemic sclerosis and pulmonary arterial hypertension: Results from the TRAX database
    Denton, CP
    Coghlan, J
    Black, CM
    Hoeper, MM
    Kiely, DG
    Carlsen, J
    Van Lierop, C
    Humbert, M
    ANNALS OF THE RHEUMATIC DISEASES, 2005, 64 : 294 - 294
12345